Literature DB >> 27867967

Fatty acid binding proteins as biomarkers of disease severity and response to treatment in severe pneumonia required admission to intensive care unit.

Han-Chen Tsai1, Shi-Chuan Chang2.   

Abstract

Entities:  

Year:  2016        PMID： 27867967      PMCID： PMC5107406          DOI： 10.21037/atm.2016.10.38

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  16 in total

1.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Authors:  Elisa Ghelfi; Cagatay Karaaslan; Sara Berkelhamer; Serra Akar; Harry Kozakewich; Sule Cataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

Review 2.  Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.

Authors:  You-Dong Wan; Tong-Wen Sun; Zi-Qi Liu; Shu-Guang Zhang; Le-Xin Wang; Quan-Cheng Kan
Journal:  Chest       Date:  2016-01-06       Impact factor: 9.410

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

4.  Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

Authors:  Pedro P España; Alberto Capelastegui; Inmaculada Gorordo; Cristobal Esteban; Mikel Oribe; Miguel Ortega; Amaia Bilbao; José M Quintana
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

5.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

6.  Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.

Authors:  Thomas J Marrie; M Reza Shariatzadeh
Journal:  Medicine (Baltimore)       Date:  2007-03       Impact factor: 1.889

Review 7.  Is the present definition of health care-associated pneumonia the best way to define risk of infection with antibiotic-resistant pathogens?

Authors:  Vanessa Yap; Debapriya Datta; Mark L Metersky
Journal:  Infect Dis Clin North Am       Date:  2012-12-25       Impact factor: 5.982

8.  Intensive Care Unit Admission With Community-Acquired Pneumonia.

Authors:  Adam S Vohra; Hyo Jung Tak; Maulin B Shah; David O Meltzer; Gregory W Ruhnke
Journal:  Am J Med Sci       Date:  2015-11       Impact factor: 2.378

9.  SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.

Authors:  Patrick G P Charles; Rory Wolfe; Michael Whitby; Michael J Fine; Andrew J Fuller; Robert Stirling; Alistair A Wright; Julio A Ramirez; Keryn J Christiansen; Grant W Waterer; Robert J Pierce; John G Armstrong; Tony M Korman; Peter Holmes; D Scott Obrosky; Paula Peyrani; Barbara Johnson; Michelle Hooy; M Lindsay Grayson
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

Review 10.  Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.

Authors:  James D Chalmers; Catriona Rother; Waleed Salih; Santiago Ewig
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.